CV institute co-director sees potential for high-impact research
A general and preventive cardiologist, Feinstein is an expert in managing cardiovascular risk in individuals throughout the life course.
Clinical research spotlight: Lauren Magee, PhD
Lauren Magee, PhD, implements and evaluates interventions that provide necessary behavioral and social support services for firearm injury survivors and their families within clinical and
First clinical trial of Tremfya for pediatric ulcerative colitis underway
Researchers at the IU School of Medicine are yielding positive results in the first and only clinical trial of Tremfya for a pediatric patient with
IU researchers study blue light impact on circadian rhythm and vision
How is screen time affecting your eyes and sleep? Researchers at the IU School of Medicine Department of Ophthalmology are studying how blue light from
Researchers identify potential new way to protect glaucoma patients' vision
Indiana University School of Medicine researchers have discovered a possible way to protect nerve cells impacted by glaucoma.
IU neurologists develop new app aimed at improving stroke care for Spanish-speaking patients across Indiana
Neurologists at the Indiana University School of Medicine have developed a new app designed to help reduce communication barriers and improve stroke assessments and long-term
Basic science research spotlight: Dan Peltier, MD, PhD
Dan Peltier, MD, PhD research aims to determine whether any undescribed long non-coding RNA genes may regulate the T cells that drive GVHD.
IU study explains why current hemophilia A gene therapies may be missing the mark
IU researchers have mapped the source of the blood-clotting protein missing in people with hemophilia A, paving the way for more effective gene therapies for
IU neurotrauma researchers discover FDA-approved drug can be repurposed as treatment for spinal cord injury
Researchers at the IU School of Medicine have discovered that a FDA-approved drug that's widely used as a sedative in hospitals can be repurposed as
IU neuropsychologist's Fulbright journey accelerates addiction research
David Kareken, professor of neurology and director of the Indiana Alcohol Research Center, spent four months in France conducting functional neuroimaging research as part of